PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Stephan Niland

University of Münster

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 18, 2026 · JOURNAL ARTICLE

Transport of cytotoxic cyanine dyes coupled to siRNA into hematopoietic cancer cells with CD20-, CD22- or CD33-targeting ELART nanocarriers

Scientific Reports

Proof-of-concept study demonstrating nanocarrier delivery of cytotoxic agents to hematopoietic cancer cells in vitro; early-stage work without efficacy endpoints, clinical data, or comparative controls required to establish clinical relevance.

PreliminaryStephan Niland Nanoparticle-based Drug Delivery Katharina Grunert

Reported

Internalization timeframe1–4 h

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support